Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes by unknown
SHORT REPORT Open Access
Direct conversion of mouse embryonic
fibroblasts into functional keratinocytes
through transient expression of
pluripotency-related genes
Demetris Iacovides1†, Gizem Rizki1,3†, Georgios Lapathitis2 and Katerina Strati1*
Abstract
The insufficient ability of specialized cells such as neurons, cardiac myocytes, and epidermal cells to regenerate after
tissue damage poses a great challenge to treat devastating injuries and ailments. Recent studies demonstrated that
a diverse array of cell types can be directly derived from embryonic stem cells (ESCs), induced pluripotent stem cells
(iPSCs), or somatic cells by combinations of specific factors. The use of iPSCs and direct somatic cell fate conversion, or
transdifferentiation, holds great promise for regenerative medicine as these techniques may circumvent obstacles related
to immunological rejection and ethical considerations. However, producing iPSC-derived keratinocytes requires a lengthy
two-step process of initially generating iPSCs and subsequently differentiating into skin cells, thereby elevating the risk of
cellular damage accumulation and tumor formation. In this study, we describe the reprogramming of mouse embryonic
fibroblasts into functional keratinocytes via the transient expression of pluripotency factors coupled with directed
differentiation. The isolation of an iPSC intermediate is dispensable when using this method. Cells derived with
this approach, termed induced keratinocytes (iKCs), morphologically resemble primary keratinocytes. Furthermore
they express keratinocyte-specific markers, downregulate mesenchymal markers as well as the pluripotency factors
Oct4, Sox2, and Klf4, and they show important functional characteristics of primary keratinocytes. iKCs can be further
differentiated by high calcium administration in vitro and are capable of regenerating a fully stratified epidermis in vivo.
Efficient conversion of somatic cells into keratinocytes could have important implications for studying genetic
skin diseases and designing regenerative therapies to ameliorate devastating skin conditions.
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Introduction
The ability to generate differentiated cells from pluripotent
cells holds great promise for regenerative medicine. Re-
cently emerged techniques to reprogram somatic cells into
induced pluripotent stem cells (iPSCs) and to transdiffer-
entiate cells into different fates offer unprecedented possi-
bilities to repair or replace damaged tissues [32, 33, 37].
These techniques potentiate autologous cell replacement
therapies, thus minimizing issues of immune rejection and
ethical constraints posed by embryonic stem cell (ESC)
isolation. Although ESCs and iPSCs possess tremendous
differentiation potential, efficiency of differentiation, risk
of tumor formation, and accumulation of DNA damage
during in-culture maintenance pose challenges to utilizing
these cells in translational applications. In vivo reprogram-
ming, or direct lineage conversion, can minimize unneces-
sary ex vivo manipulation of cells thereby reducing the
risk of damage accumulation during reprogramming [5].
Recent studies demonstrate the feasibility of generating
functional cells within native tissues via transdifferentia-
tion. For example, forced expression of critical cardiac
transcription factors in mouse hearts can stimulate the
regeneration of de novo cardiomyocyte-like cells from ter-
minally differentiated fibroblasts after ischemic heart
damage [25, 29]. Reprogramming strategies have also been
invaluable in studying and replicating cell types, such
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as neurons, with limited regenerative potential. Using
patient-derived iPSCs, neurological and psychiatric dis-
eases, including Alzheimer’s and schizophrenia, have
been modeled in culture, providing crucial insights into
disease mechanisms [9, 17]. Furthermore, several types
of neurons, including multipotent progenitors, can be
derived from pluripotent or differentiated cell types and
have been used in proof-of-principle cell replacement
studies in mouse models with successful therapeutic
outcomes [21, 24, 36, 38]. These studies open up previously
unrecognized avenues for the application of reprogram-
ming to treat dementia, Alzheimer’s, and other neurode-
generative diseases. While most of these coming-of-age
technologies have advanced the fields of reprogramming
and regenerative medicine, there is an urgent need for more
efficient cellular regeneration and repair paradigms.
The skin is a tissue that is highly prone to external injury
or cancer development and is easily accessible, making it
amenable to cell replacement therapy. Currently, tissue
grafting is the most common skin tissue replacement
therapy for extensive burns, acute and chronic wounds,
reconstructive surgery, and genetic conditions such as
epidermolysis bullosa [34, 35]. Skin grafting, which re-
quires transplantation of donor tissue onto the wound,
is often restricted by the availability of donor skin. In
recent years, the use of cultured epithelial autografts
(CEAs) generated by isolating and expanding epidermal
stem cells (keratinocytes) in culture have provided a
more effective tool to generate sheets of autologous skin
cells, cover wounds, and enhance healing [3]. However, the
long culturing periods necessary to obtain keratinocyte
sheets, surgical complications of engrafting CEAs, and vari-
able success rates of wound closure represent serious short-
comings of this procedure. More recently, methodologies
to differentiate keratinocytes either from pluripotent ESCs
or iPSCs have been described, thus providing an alternate
source of skin cells [2, 7, 8, 18]. In an effort to improve
keratinocyte derivation and to circumvent the challenges
posed by using ESCs or iPSCs, we established a new para-
digm for the conversion of mouse fibroblasts to functional
keratinocytes, bypassing the isolation of a pluripotent inter-
mediate. Our approach has the potential to facilitate effi-
cient and large-scale keratinocyte generation for biological
research and future cell-based regenerative applications.
Materials and methods
Cell culture
iPSC media were prepared with Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 75 mL (15 %) knock-
out serum replacement (KSR), 5 mL (1 %) 5000 U/ml peni-
cillin/streptomycin (P/S), 5 mL 50 mM BME, and 5 mL
MEM non-essential amino acids (Gibco, cat. #11140-050).
Mouse embryonic fibroblast (MEF) media contained 1×
DMEM, 10 % fetal bovine serum, and 1 % P/S. When
necessary, media were also supplemented with 500 μL
LIF (106 units/ml; Millipore, cat. #ESG1106). Defined
keratinocyte serum free (DKSF) media were obtained
from CellnTec, and were supplemented with 5 mL P/S.
For the attachment of keratinocytes, cell culture dishes
were coated with fibronectin (50 μg/mL) and collagen
(100 μg/mL) for 20 min at 37 °C before culture. Kerati-
nocytes (KCs) were cultured in medium low in calcium
(0.07 mM) to maintain an undifferentiated status, and
were differentiated in medium with a high calcium con-
centration (0.35 mM) to induce differentiation.
Transfection and transduction
Actively growing 293 T cells were transfected with pCL-
Eco, pSox2, pOCT4, pKlf4, or pGFP plasmids at 70 %
confluency using Fugene 6 transfection reagent (Roche,
cat. #11988387001) according to the manufacturer’s proto-
col. Cell media were changed the next day, and superna-
tants containing retroviral vectors were collected 48-h
post-transfection and filtered through a 45-μm filter. Poly-
brene (Milipore cat. #TR-1003) was added at 10 μg/mL
and 1 mL from each transcription factor was then used to
transduce MEFs that were previously passaged only once.
Transduction was repeated four times with at least 6-h in-
tervals between.
RNA extraction and quantitative reverse transcription PCR
RNA was extracted from MEFs, primary keratinocytes,
and induced keratinocytes (iKCs) using the RNeasy kit
(Qiagen, cat. #74104), DNase-treated with TURBO DNA-
free kit (Ambion, cat. #AM1907), and quantified using
NanoDrop. cDNA synthesis was performed using the
iScript DNA synthesis kit (Bio-Rad, cat. #170-8890);
100 ng cDNA from each sample was then used as a
template for polymerase chain reaction (PCR) using Kapa-
Taq polymerase (KAPA BIOSYSTEMS, cat. #KK1014) and
primers specific to keratinocyte markers (K14, K5, K8, K1),
fibroblast markers (vimentin), and actin. Primer sequences
were as follows:
K14: ACCGCAAGGATGCTGAGGA (fwd), GAAATC
TCACTCTTGCCGCTCTG (rev); K8: TGCAGAACATG
AGCATTC (fwd), CAGAGGATTAGGGCTGAT (rev);
K1: TCGTGACCATCAAGAAGGAT (fwd), ACAACATT
GGTTTCGCTGAT (rev); K5: CAAATCGACCCCACC
ATCCA (fwd), GAACCGCACCTTGTCGATGA (rev);
vimentin: GACCGCTTTGCCAACTACATC (fwd), AGC
ATCTCCTCCTGCAATTTCT (rev); p63: AACCCCAG
CTCATTTCTCGT (fwd), GGCCCGGGTAATCTGTGT
TGG (rev); total Oct-4: CCAATCAGCTTGGGCTAGAG
(fwd), CTGGGAAAGGTGTCCCTGTA (rev); total Sox-2:
ATGGGCTCTGTGGTCAAGTC (fwd), CCCTCCCAAT
TCCCTTGTAT (rev); total Klf-4: CTGAACAGCAGGG
ACTGTCA (fwd), GTGTGGGTGGCTGTTCTTTT (rev);
endogenous Oct-4: TCTTTCCACCAGGCCCCCGGCTC
Iacovides et al. Stem Cell Research & Therapy  (2016) 7:98 Page 2 of 12
(fwd), TGCGGGCGGACATGGGGAGATCC (rev); en-
dogenous Sox-2: TAGAGCTAGACTCCGGGCGATGA
(fwd), TTGCCTTAAACAAGACCACGAAA (rev); en-
dogenous Klf-4: GCGAACTCACACAGGCGAGAAACC
(fwd), TTAGGCTGTTCTTTTCCGGGGCCACGA (rev)
(endogenous Oct-4, Sox-2 and Klf-4 primer sequences
from [33]; actin: CATCCGTAAAGACCTCTATGCCAAC
(fwd), ATGGAGCCACCGATCCACA (rev). For quantita-
tion of reverse transcription (RT)-PCR, keratinocyte and
fibroblast marker expression was normalized to actin.
Experiments were performed in triplicates and statis-
tical significance was determined using a t test.
Isolation of cells
MEFs were obtained by crossing FVB-Tg (KRT14-cre)
mice (NCI mouse repository) with R26-stop-EYFP mice
(Jackson laboratory, stock #006148). MEFs were isolated
as follows: The uterus of the pregnant mouse was re-
moved at day 13.5 post-conception and collected in
phosphate-buffered saline (PBS) + antibiotics. Embryos
were transferred to a 10-cm dish with PBS + antibiotics,
and heads and viscera were cut off. The remaining body
of each embryo was then transferred into a 6-cm dish
with 1 ml 0.1 % trypsin solution and chopped up well
with a razor blade. The dish was then incubated in a
37 °C incubator for 20 min, and the cell mixture was
subsequently pipetted up and down 15–20 times to dis-
perse the suspension of cells, and left in the incubator
for an additional 20 min. At the end of incubation,
15 ml DMEM+ 10 % fetal calf serum was added to each
dish, and cells were transferred to a T75 flask for culture.
Primary keratinocytes were isolated from 2- to 4-day-old
newborn mice. Following euthanasia, mice were soaked in
betadine solution for 5 min, followed by 3× washes with
70 % ethanol. Limbs, tail, and the small part of the snout
were subsequently removed, and a longitudinal cut from
the snout to the tail was performed to enable skin removal.
Skin was then peeled off and stretched on a sterile surface
(dermis side down) and floated in 0.25 % trypsin overnight
at 4 °C. The next day, skin was transferred to a sterile sur-
face, with the epidermis side down, and the dermis was
peeled off. The remaining epidermis was then minced with
a razor blade and placed in a Falcon tube with complete
KC medium supplemented with 1.4 mM Ca2+ for 1 h at
37 °C on a stirrer to obtain a single cell suspension. The
cell suspension was then filtered through a cell strainer,
and cells were plated on culture dishes pre-coated with
collagen and fibronectin.
Immunofluorescence
Cells were plated on coverslips pre-coated with poly-L
lysine for 5 min. Next day, they were fixed with 4 %
paraformaldehyde for 15 min at room temperature,
washed twice with PBS for 5 min, permeabilized with
0.5 % Triton-X for 10 min at room temperature and
washed three times with PBS (5 min each time). Fixed
cells were then incubated in PBG blocking buffer (0.2 %
cold water fish gelatin (SIGMA G-7765), 0.5 % bovine
serum albumin (SIGMA A-2153) in PBS) for 30 min at
room temperature, and incubated in PBG plus primary
antibody for 2 h at room temperature, and washed twice
with PBG for 5 min, followed by 45-min incubation in
PBG plus FITC-labeled anti-rabbit secondary antibody
(Jackson, cat. #715-095-150). Nuclei were stained with
100 ng/mL DAPI stain in PBG, followed by 2× washes
with PBS for 5 min. Coverslips were then placed on
slides with mounting medium (Vector Labs, cat. #H-
1000) and viewed under a fluorescent microscope. Pri-
mary antibodies used were rabbit polyclonal to vimentin
(Abcam, cat. #ab45939) and rabbit polyclonal to keratin
14 (Covance, cat. #PRB-155P).
Western blot analysis
Cells were lysed in RIPA buffer, and protein concentra-
tion was determined with the Bio-Rad Protein assay
using protein assay dye reagent concentrate (Bio-Rad,
cat. #500-0006). Total lysates were separated on a 10 %
SDS-PAGE gel for 1 h at 200 V. Proteins were subse-
quently transferred to a nitrocellulose membrane via
semi-transfer for 25 min at 20 V, blocked with 5 % milk
in TBS-Tween for 1 h at room temperature, and then in-
cubated with the appropriate primary antibody at 4 °C
overnight. Primary antibodies used were: rabbit polyclonal
to vimentin (Abcam, cat. #ab45939), rabbit polyclonal to
keratin 14 (Covance, cat. #PRB-155P), and rabbit poly-
clonal to actin (Abcam, cat. #ab8226). Membranes were
then incubated in blocking buffer plus anti-rabbit HRP-
conjugated secondary antibody (Santa Cruz, cat. #SC2054)
for 1 h at room temperature and exposed using the Lumi-
Sensor™ chemiluminescent HRP substrate kit (GenScript,
cat. #L00221V500).
Tissue fixation, embedding, and staining
Skin removed from transplanted nude mice was fixed in
4 % freshly prepared paraformaldehyde overnight at 4 °C,
and paraffin-embedded according to standard protocols.
Paraffin-embedded tissues were sectioned into 10-μm sec-
tions, placed on glass slides, deparaffinized with xylene,
and rehydrated in sequentially decreasing concentrations
of ethanol. Slides were subsequently rinsed in PBS
(2 × 3 min), microwaved at 130 °C for 10 min for anti-
gen retrieval, and rinsed again with PBS (2 × 3 min).
Tissue sections were blocked in 5 % horse serum in PBS
for 2 h at room temperature, and treated overnight at 4 °C
with the appropriate primary antibody diluted in block
buffer. To visualize yellow fluorescent protein (YFP)-posi-
tive cells in epidermal tissue, we used an antibody against
green fluorescent protein (GFP; Abcam, cat. #Ab290)
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which can recognize YFP, since this protein is a GFP point
mutant. Primary antibodies used were anti-K14 at 1:1000
(Covance, cat. #PRB-155P), anti-K10 at 1:250 (Santa Cruz
Biotechnology, cat. #sc-23877), and anti-loricrin at 1:250
(Covance, cat. #PRB-145P). Slides were then rinsed with
PBS (2 × 3 min) and incubated for 45 min at room
temperature in FITC-labeled (Jackson, cat. #715-095-150)
or Cy3-labeled secondary antibody (Jackson, cat. #715-
165-150) diluted 1:250 in block buffer. Samples were
then mounted with mounting medium (Vector Labs,
cat. #H-1000) and viewed under a fluorescent micro-
scope. For hematoxylin and eosin (H&E) staining, tissue
samples on glass slides were deparaffinized in xylene
(2 × 10 min), rehydrated in sequentially decreasing con-
centrations of methanol, and subsequently stained with
hematoxylin solution for 5 min, rinsed in tap water and
placed in 5 % HCl/70 % EtOH solution for 30 s, followed
by another rinse in tap water and incubation in eosin solu-
tion for 3 min. Slides were then rinsed off in tap water
and tissues were dehydrated in increasing concentrations
of methanol, incubated in 100 % ethanol for 5 min
followed by 10 min incubation in xylene, and mounted
using VectaMount permanent mounting medium (Vector
Labs, cat. #H-5000).
Cell grafting in nude mice
For cell transplantation experiments, athymic nude mice
were used as previously described [20]. Briefly, mice
were sedated with tribromoethanol (Sigma-Aldrich, cat.
#T48402) at 0.2 mL per 10 g body weight. The backs of
animals were decontaminated with betadine and 70 %
ethanol. Using fine forceps, the full back skin was lifted
and cut with scissors creating a graft area with a 1-cm
diameter. A dome flange (Renner, cat. #F2 U 30268) was
then inserted under the skin and tucked safely in place
with wound clips. Cell suspensions were then applied to
the graft area using a pipette through the hole on the
top part of the dome flange. This study was carried out
in strict accordance with the recommendations in the
Guidelines for the Protection of Laboratory Animals of
the Republic of Cyprus. The protocol was approved by
the Veterinary Services (Republic of Cyprus Ministry of
Agriculture, Rural Development and Environment; License
number CY/EXP/PR.L1/2013). All euthanasia was per-
formed by adhering to appropriate guidelines using a
CO2 chamber, and all efforts were made to minimize
suffering.
Results
Generation of induced keratinocytes from mouse
embryonic fibroblasts
Prior publications have described methods to differentiate
mouse- or human-derived iPSCs or ESCs into epidermal
keratinocytes in vitro by sequential administration of
differentiation factors comprising retinoic acid (RA)
and bone morphogenetic protein (BMP) [7, 8, 18]. Al-
though direct lineage conversion between somatic cells
of different types has been reported in the literature
[36], generation of skin cells via direct reprogramming has
not been demonstrated. To improve current keratinocyte-
derivation technologies involving an iPS intermediate,
we attempted to obtain keratinocytes directly from MEFs
in vitro (Fig. 1a). We reasoned that a brief initiation
of pluripotency-inducing transcriptional reprogramming
mechanisms followed by directed differentiation towards
the epidermal lineage may promote fibroblasts to switch to-
wards the ectodermal fate, without fully committing to an
iPS state. Recently, it was shown that such transient induc-
tion of pluripotency-related genes may be a viable option to
transdifferentiate MEFs into other cell types via a non-
isolated plastic state in order to differentiate in a directed
manner [5, 19, 22]. Importantly, while prolonged systemic
activation of these factors in vivo was previously
shown to lead to teratoma formation [1], transient
and/or localized delivery was not associated with
adverse effects [22] even if c-Myc was included in the
reprogramming mix [11, 39].
To this end, MEFs isolated from 2-day-old newborn
mice and passaged only once were transduced with retro-
viral vectors expressing Sox2, Oct4, and Klf4 pluripotency-
associated factors as previously described [33]. We
repeated transduction twice a day for 2 days and the day of
the fourth transduction was designated as day 0 of the
experiment. The next day (day 1) we switched cell culture
media to iPSC/ESC media and cells were left in culture for
4 days to allow for the expression of the transduced pluri-
potency factors and ensure enough time for initiation of
pluripotency-related transcriptional reprogramming, which
was previously shown to be initiated as early as 3 days after
Sox2, Oct4, and Klf4 expression [30]. To promote the ecto-
dermal fate we exposed cells to 0.3 μg/mL RA in iPSC/
ESC media without LIF on day 4 [4] and continued cultur-
ing in RA until day 8, at which time it was removed. To
block progression into the neural fate [13], cells were sub-
sequently treated with 50 ng/mL BMP-4 and cultured for
an additional 4 days. On day 12, cells were trypsinized and
plated onto collagen/fibronectin-coated dishes, cultured in
DKSF media and allowed to grow until day 20, at which
time they were expanded into 60-mm dishes as described
previously [7]. Since undifferentiated epidermal stem cells
have been shown to rapidly attach collagen-coated sur-
faces, unlike differentiated skin cells [6, 7], RA/BMP-4
treated cultures were trypsinized, plated on collagen/fibro-
nectin-coated dishes and allowed to attach for 15 min to
enrich for keratinocytes. Unattached cells were washed off
with PBS and the remaining population was cultured in
DKSF medium until further expansion was necessary. We
repeated the rapid-attachment procedure for two more
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passage cycles and subsequently harvested induced kerati-
nocytes for additional experiments or froze the cells down
in DKSFM+ 10 % DMSO for future use (Fig. 1b).
The cells obtained using this approach, which will hence-
forth be referred to as induced keratinocytes (iKCs), looked
markedly different from MEFs and exhibited keratinocyte-
like properties. In contrast to MEFs, iKCs appeared mor-
phologically identical to primary keratinocytes in culture,
displaying a rounded cellular morphology and forming
colonies with a cobblestone-like appearance, a hallmark of
primary keratinocytes in culture (Fig. 2a). MEFs mock-
infected with control retrovirus constructs and incu-
bated with RA/BMP-4 and DKSF media did not give
rise to iKCs (data not shown), confirming that the deriva-
tion of keratinocytes depended on our transdifferentiation
protocol and was not due to contaminating keratinocytes
in the MEF preparations.
Molecular characterization of induced keratinocytes
To ensure that the iKCs that displayed keratinocyte-like
morphology were indeed skin stem cells, we further
characterized iKCs at a molecular level. Using semi-
quantitative RT-PCR we next measured the expression
levels of keratinocyte and fibroblast markers in iKCs. In
contrast to MEFs, iKCs expressed the undifferentiated
keratinocyte markers keratin14 (K14) and keratin5 (K5)
at levels comparable to those of primary keratinocytes
(Fig. 2b). iKCs also expressed p63, an important gene in
the commitment to keratinocyte fate, but at a level lower
than that seen in primary keratinocytes. Even though the
expression of vimentin, a fibroblast marker, was not
completely abolished in iKCs, it was reduced by twofold
compared to MEFs (Fig. 2b). These results were further
confirmed using immunofluorescence staining and mi-
croscopy (Fig. 2c) as well as Western blotting (Fig. 2d).
iKCs showed reduced expression of cytoplasmic vimen-
tin, and exhibited a more round morphology than their
parental MEFs. In contrast, MEFs expressed high levels
of vimentin, which was clearly present in the cytoskeleton
of these mesenchymal cells as expected. Similarly, iKCs
expressed K14 protein, in contrast to the parental MEFs
(Fig. 2c and d). Overall, our molecular experiments con-
firmed that the iKCs express characteristic keratinocyte-
specific genes and begin to repress fibroblast markers,
thereby resembling normal isolated keratinocytes. Import-
antly, expression of the reprogramming factors Oct4,
A
B
Fig. 1 Conversion of mouse embryonic fibroblasts (MEFs) to functional keratinocytes (KCs), without isolating an induced pluripotent stem cell
(iPSC) intermediate. a The hypothesis behind the experimental design. b After a brief initiation of pluripotency-inducing transcriptional reprogramming
by transduction with Sox2, Oct4, and Klf4, induced MEFs are subsequently pushed towards the epidermal lineage by retinoic acid (RA) and bone
morphogenetic protein-4 (BMP-4) treatment. DKSF defined keratinocyte serum free, IKC induced keratinocyte




Fig. 2 (See legend on next page.)
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Sox2, and Klf4 is silenced in the reprogrammed cells
(Fig. 2e). This was assessed using primers for both en-
dogenous and total levels of the factors.
Functional characterization of induced keratinocytes
Multipotent primary mouse keratinocytes have the cap-
acity to differentiate in response to elevated extracellular
calcium (Ca2+) concentrations. High calcium levels in-
duce the expression of intermediate and terminal differ-
entiation markers, such as K1 and K8, respectively, and
result in stratification of keratinocytes [40]. In order to
further characterize our iKCs in vitro, we next tested
their differentiation potential under high Ca2+ condi-
tions. Indeed, primary KCs cultured under a high Ca2+
concentration (0.35 mM) flattened out and appeared
stratified, in contrast to cells cultured in low calcium
(0.07 mM), which were round and unstratified (Fig. 3a,
panels a and b). iKCs recapitulated characteristics of pri-
mary keratinocytes under these conditions, where exten-
sive stratification was evident after an increase in Ca2+
levels (Fig. 3a, panels c and d). Cells cultured under high
Ca2+ conditions upregulated the expression of the differ-
entiation markers K1 and K8, unlike those cultured in
low Ca2+ media (Fig. 3b). In addition, expression of K14,
a marker of undifferentiated keratinocytes, was reduced
in iKCs upon elevated Ca2+ levels and this reduction was
comparable to that observed in primary keratinocytes
(about 30 %) (Fig. 3b). These results suggest that iKCs
derived from reprogrammed MEFs can be maintained in
an undifferentiated state in vitro, are capable of differen-
tiating in response to extracellular signals, and express
differentiation markers similar to primary keratinocytes.
Undifferentiated keratinocytes possess the ability to re-
generate normal skin and hair when grafted on nude
mouse skins. To test whether iKCs were multipotent and
thereby could differentiate and regenerate normal skin in
vivo, we performed in vivo grafting in nude mice as des-
cribed previously [20] and detailed in the Materials and
methods section above. iKCs or MEFs were transplanted
into chambers implanted under the back skin of nude
mice. Approximately 6 weeks after grafting, nude mice
transplanted with iKCs showed de novo hair formation at
the graft site, whereas hair development was not observed
in mice transplanted with MEFs (Fig. 4a, panels a and b).
Mice were subsequently sacrificed and the skin from the
graft area was collected for histological examination. iKCs
were able to regenerate all layers of the epidermis, not-
ably de novo hair follicles and sebaceous glands (Fig. 4a,
panel c). In contrast, epidermal development of the
MEF-grafted skin sections appeared incomplete, with
no hair development and a thinner epidermis (Fig. 4a,
panel d). When we measured the epidermal thickness
of skin samples from both transplantation conditions,
we indeed observed that the epidermis generated by
differentiated iKCs was nearly twofold thicker than the
epidermis generated at the MEF-transplanted site (Fig. 4b).
The presence of hair growth, hair follicles, and sebaceous
glands in iKC grafts, but not MEF-grafted skins, pro-
vides further evidence that iKCs are functional and can
differentiate to give rise to different epidermal layers in
vivo.
We originally used MEFs isolated from F1 mice de-
rived from an R26-stop-EYFP × KRT14-cre cross, which
could be used as a reporter to monitor K14 expression
in cells. We hypothesized that the de novo epidermal tis-
sue generated by iKCs should be positive for EYFP if the
differentiated cells arose from the transplanted iKCs. In
order to trace the origin of the cells contributing to
epidermal regeneration, we used an antibody against
GFP to detect EYFP levels by immunofluorescence. In-
deed, EYFP staining was observed across the full epi-
dermis of the iKC-transplanted animals, including all
epidermal layers, the hair follicle, and the bulge (Fig. 4a,
panel e). Conversely, the grafts from MEF-transplanted
skins did not exhibit any EYFP staining, suggesting that
the minimal epidermal regeneration that occurred in
these animals was possibly due to keratinocytes in the
host (Fig. 4a, panel f ).
(See figure on previous page.)
Fig. 2 Morphological and molecular characterization of induced keratinocytes. a Induced keratinocytes (iKCs) exhibit keratinocyte-like morphological
properties, closely resembling primary keratinocytes (1°KCs) in culture. iKCs displayed a round shape and formed colonies with a cobblestone-
like appearance, a characteristic of primary keratinocytes in culture. In contrast, parental mouse embryonic fibroblasts (MEFs) exhibit mesenchymal
characteristics, as they appear spindle shaped and do not form colonies. Scale bars = 25 μm. (b) Expression levels of keratinocyte and fibroblast markers
were measured by semi-quantitative RT-PCR, and agarose gel electrophoresis showing the product of each PCR reaction is depicted. The relative levels
of each product from three independent experiments were normalized to actin. Results are depicted as fold-change of expression compared
to expression in either primary keratinocytes (K14, K5, and p63) or in MEFs (vimentin). Error bars represent standard error between experiments.
In contrast to MEFs, iKCs expressed undifferentiated keratinocyte markers (K14 and K5) at levels comparable to those of primary keratinocytes;
p63 expression was threefold higher in iKCs compared to MEFs, even though KCs expressed p63 at much higher levels; vimentin expression
was reduced twofold in iKCs, albeit not completely abolished. c Immunofluorescence staining against vimentin (Vim) and keratin 14 (K14) in
MEFs, primary KCs, and iKCs. DAPI staining is shown in blue, and Vim or K14 staining is shown in green. Scale bars = 20 μm. (d) Western blot
analysis to measure vimentin and K14 protein levels in MEFs and iKCs. Total cellular protein lysates were run and blotted with anti-vimentin and anti-K14
antibodies, as well as with anti-actin as a control. e Endogenous and total expression levels of pluripotency factors Klf4, Sox2, and Oct4 were assessed by
RT-PCR in MEFs, KCs, and iKCs. ESCs were included as a positive control. Expression of these factors is silenced in iKCs
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We next measured the expression of specific markers
of various epidermal layers in the normal epidermis to
determine whether the newly formed epidermis was cor-
rectly stratified. The undifferentiated marker K14 was
expressed in the basal layer of the grafts in both the
MEF-transplanted and iKC-transplanted mice (Fig. 4c,
panels a and b). K10, a marker of intermediate differen-
tiation, was detected at high levels in the layer immedi-
ately adjacent to the K14-positive stratum in iKC tissues
but was barely detectable in the epidermis derived from
the MEF-transplanted site (Fig. 4c, panel b). Finally, lori-
crin that is normally expressed in differentiated epithe-
lium was observed on the outer epidermal layer of the
iKC-derived skins. In contrast, MEF grafts did not display
any loricrin staining (Fig. 4c, panels c and d). Collectively,
these results indicate that keratinocytes obtained by trans-
differentiation of MEFs in vitro have the capacity to re-
constitute the fully stratified epidermis when transplanted
onto nude mice.
Conclusion
A critical limitation to cell replacement therapeutics is
the procurement of good quality cells, in large enough
numbers, with low chance of immune rejection. In the
case of treatment of wounds caused either by physical
causes, such as burns, or by disease, such as diabetic ul-
cers, cell replacement therapies have been extensively
used [34, 35]. Keratinocytes which can be used as grafts
or as a component of other more complex matrices to
enhance re-epithelialization of a wound are a limited re-
source [14]. Derivation of keratinocytes from ESCs or
iPSCs has been described as a way to generate larger
numbers of these cells for cell replacement therapies or
disease modeling [2, 7, 8, 18]. Recently, the transient
expression of pluripotency-related factors followed by
directed differentiation [5, 22] has been proposed as a
potentially superior way to derive reprogrammed differ-
entiated cells. This approach, as well as other transdiffer-
entiation approaches, minimize ex vivo manipulation of
cells without necessarily compromising safety [22, 39].
We describe in this manuscript a novel methodology
for the direct conversion of mouse fibroblasts into in-
duced keratinocytes. This methodology eliminates many
intermediate steps necessary to generate iPSCs as a
prerequisite, and has the potential for future adaptation
in the native tissue. Molecular as well as in vitro and in
vivo functional validation confirms the fidelity of these
reprogrammed cells to primary keratinocytes. iKCs
downregulate the expression of key mesenchymal
markers, such as vimentin, and display elevated expres-
sion of several keratinocyte-specific genes, such as kera-
tins. It has been previously reported that reprogrammed
cells do not reach the full spectrum of transcriptional or
other characteristics of the desired cell population [23].
Often, further culturing of the cells or other reprogram-
ming modifications may lead to higher expression fidel-
ity. It is important to note that cell functionality does
not necessarily correlate with exactly similar transcrip-
tional profiles. Furthermore, some transcriptome vari-
ation also exists among populations of the same type of
cells [26]. A testament to their functionality, iKCs pos-
sess the ability to differentiate in response to increased
calcium concentrations, and can regenerate skin, hair
follicles, and sebaceous glands when transplanted in the
backs of nude mice. Importantly, iKCs no longer express
the reprogramming factors, which is a critical consider-
ation for their safety in future in vivo applications.
Several improvements can contribute to the optimization
of this technology towards the large-scale derivation of in-
duced human keratinocytes for use in in vitro disease
models or cell replacement studies, and potentially in vivo
wound-healing approaches. Use of safer vectors, improve-
ment of efficiency of reprogramming, and overall fidelity of
generated cells to the natural cell type are a few examples
of issues that generally apply to the majority of current re-
programming technologies. Efficiency of reprogramming
and fidelity to the natural cell types are affected in part by
intrinsic properties of the starting cells. For example, there
are several reports suggesting that proliferation is essential
for reprogramming and that a higher proliferation in the
starting cell population correlates with higher repro-
gramming efficiency [27]. Nevertheless, excessive cellu-
lar proliferation associated with an upregulation of the
growth factor signaling pathway has been reported to
have an adverse effect on reprogramming [15].
It is of interest that the iKCs reported here seem to
express keratinocyte-specific markers at levels slightly
lower than keratinocytes, and fibroblast-specific markers at
(See figure on previous page.)
Fig. 3 Induced keratinocytes (iKCs) can differentiate in vitro. (a) To test their differentiation potential in vitro, iKCs and primary keratinocytes (1°KCs) as a
control were cultured under high (0.35 mM) and low (0.07 mM) Ca2+ concentrations. Primary KCs cultured in high calcium flattened out and differentiated
(b), in contrast to cells cultured in low calcium which remained round and undifferentiated (a). iKCs recapitulated characteristics of primary keratinocytes
under these conditions, and extensive differentiation was evident after an increase in Ca2+ levels (c and d). Scale bars = 50 μm. (b) Expression
of the differentiation markers K1 and K8, as well as expression of K14, a marker of undifferentiated keratinocytes, were measured by RT-PCR
under low or high Ca2+ culture conditions, and relative levels of each transcript from three independent experiments were quantified as before. Error bars
represent standard error between experiments. Similar to primary keratinocytes, iKCs cultured under high Ca2+ conditions upregulated the expression of
K1 and K8 and downregulated expression of K14 in response to elevated Ca2+ levels
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slightly higher levels. Small changes in culture conditions
or changes as simple as prolonged culturing have previ-
ously been shown to improve the desired cell state, particu-
larly in the case of iPS generation [23, 28, 31]. However it
should be emphasized that the minor molecular differences
described here do not place a barrier to cell function in
vivo or in vitro. The degree to which reprogrammed cells
should be similar to naturally occurring cells in order to be
considered equally functional is very much under debate




Fig. 4 Induced keratinocytes (iKCs) can regenerate normal skin in vivo. (a) iKCs or mouse embryonic fibroblasts (MEFs) were transplanted in the
back skin of nude mice. Nude mice transplanted with iKCs showed de novo hair formation at the graft site after 6 weeks (a), whereas hair
development was not observed on mice transplanted with MEFs (b). All layers of the epidermis, including de novo hair follicles and sebaceous
glands, are apparent in H&E stained skin sections from iKC-transplanted mice (c) but not MEF-grafted skin (d). EYFP staining (green) marks iKCs
and de novo iKC-generated tissue (e), which is not present in MEF-transplanted epidermis (f). Scale bars = 50 μm (c and d) and 10 μm (e and f).
(b) Epidermal thickness comparing iKC-derived vs MEF-transplanted skin. Blindfolded comparison was performed by measuring epidermal thickness in
25 images (two measurements/image) captured from five independent tissue sections (five images/section) from iKC-derived or MEF-derived skin. Note
a nearly twofold increase in iKC-generated epidermis. Error bars represent standard error amongst 50 independent measurements for each sample. (c)
Immunofluorescence staining for K14 (a marker of undifferentiated keratinocytes), K10 (an intermediate differentiation marker), and loricrin (a terminal
differentiation marker). Tissue sections were stained for different keratinocyte stratification/differentiation markers in iKC- or MEF-transplanted tissue
sections. IKC-transplanted epidermis expressed both K14 (green) and K10 (red), whereas MEF-transplanted tissue only displayed some K14-positive cells,
and no K10 staining (b). Loricrin (red) was expressed on the outer epidermal layer of the iKC-derived skin (c) and indicates the presence of iKC-derived
terminally differentiated cells. In contrast, MEF-derived skin was negative for loricrin expression (d). Scale bars = 10 μm
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reprogramming of various human cells with the use of p63
and KLF4, the resulting cells have a high transcriptional fi-
delity to keratinocytes. However, they fail to perform in im-
portant functional tests, perhaps due to the fact that they
express differentiated markers [10]. Although it is, of
course, informative to assess the degree of cellular conver-
sion based on transcriptional resemblance to the target
cell’s identity, the ultimate determination of proper lineage
conversion would likely depend on functional testing.
Our methodology employs the cocktail of transcription
factors typically used in the derivation of iPSCs from tran-
scription factors; however, this switches to directed differ-
entiation culture conditions shortly after viral transduction.
Using the methodology reported here we found that the re-
programmed iKCs no longer express any of the pluripo-
tency genes used for reprogramming. Technologies such as
the one described here validate earlier molecular data,
which suggest that molecular hallmarks of “stemness” arise
in reprogramming cultures long before iPS colonies are
visible, typically as early as 4 days post-expression of
pluripotency-promoting transcription factors [30]. Transi-
ent expression of reprogramming factors has recently been
described in vivo and is not associated with the oncogenic
effects seen in models where expression is sustained over
longer periods, even if c-Myc is included in the repro-
gramming factors [39]. In addition to the molecular
hallmarks of pluripotency in the early stages of repro-
gramming, functional pluripotency is also achieved, offer-
ing significant opportunities for manipulating the desired
cell state. While the isolation of an iPSC with higher fi-
delity to ESC may require longer periods of culturing,
earlier intermediates may be malleable enough for di-
rected differentiation. Such intermediates have previ-
ously been isolated and described (dubbed pre-IPS or
PiPS) [16, 22]. While they may lack key functions of
ESCs and are inappropriate for some research uses,
they may still be useful in achieving distinct differenti-
ated cell states. Importantly, in contrast to iPS, they
have been shown not to form teratomas in vivo [22].
Understanding the key steps in direct lineage-lineage
conversions will enable the transfer of the technologies in
vivo as demonstrated in cardiomyocyte studies [25, 29].
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